MIC+B12
US$ 21.70
bpc-157 risks humans BPC-157: Tendon Repair and More Tb-500 And Bpc-157 BPC-157 &
Description
Update: Had Pfizer first shot on Feb
Double the units
Given the results of animal trials, this modest benefit of antiVEGF-A/VEGFR therapy against human cancers has been relatively disappointing
But lets dig into a bit more research here
